Cargando…
Efficacy of an Immune Modulator in Experimental Chlamydia trachomatis Infection of the Female Genital Tract
Objective. The aim of this study was to determine if vaginal application of the immune response modifier imiquimod (Aldara cream, 3M Pharmaceuticals, St Paul, Minn) would alter the course and/or outcome of female genital tract infection with a human isolate of Chlamydia trachomatis in a murine model...
Autores principales: | Lyons, Joseph M., Ito, James I., Morré, Servaas A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581471/ https://www.ncbi.nlm.nih.gov/pubmed/17093354 http://dx.doi.org/10.1155/IDOG/2006/61265 |
Ejemplares similares
-
Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice
por: Lyons, Joseph M, et al.
Publicado: (2005) -
Immune Pathogenesis of Asymptomatic Chlamydia trachomatis Infections in the Female Genital Tract
por: Witkin, Steven S.
Publicado: (1995) -
The influence of vaginally applied imiquimod on the course of Chlamydia trachomatis serovar D infection in a murine model.
por: Lyons, Joseph M, et al.
Publicado: (2005) -
Persistent "silent" Chlamydia trachomatis female genital tract infections.
por: Askienazy-Elbhar, M, et al.
Publicado: (1999) -
Distribution of Chlamydia Trachomatis Genotypes in Infective Diseases of the Female Lower Genital Tract
por: Chen, Yujie, et al.
Publicado: (2017)